Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome?: An update

International Seminars in Surgical Oncology

Volumn 3, Issue , 2006, Pages

  Chaudhry, Anushka ^a   Puntis, Michael L ^a   Gikas, Panos ^a   Mokbel, Kefah ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b Princess Grace Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; SOMATOMEDIN; VASCULOTROPIN;

ADRENERGIC STIMULATION; BLEEDING; BREAST CANCER; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EVIDENCE BASED MEDICINE; FEMALE; FOLLICULAR PHASE; HORMONE ACTION; HUMAN; IMMUNE DEFICIENCY; INTRAOPERATIVE PERIOD; LUTEAL PHASE; MENSTRUAL CYCLE; OVARY FOLLICLE; OVARY FUNCTION; OVERALL SURVIVAL; OVULATION; PREMENOPAUSE; REVIEW; TREATMENT OUTCOME;

EID: 33751161015     PISSN: 14777800     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-3-37     Document Type: Review

References (44)

1. Cancer Statistics: Registrations, series MBI 33. Office for National Statistics. Ref Type: Generic
2. Fentiman IS, Gregory WM: The hormonal milieu and prognosis in operable breast cancer. Cancer Surv 1993, 18:149-163.
3. Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD: Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 1994, 30A(4):445-448.
4. Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T: A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma. Cancer 2001, 91(10):1854-1861.
5. Sariguney Y, Demirtas Y, Findikcioglu F, Ayhan S, Latifoglu O, Cenetoglu S, Celebi C: Proper timing of breast reduction during the menstrual cycle. Ann Plast Surg 2004, 53(6):528-531.
6. Macleod J, Fraser R, Horeczko N: Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? J Surg Oncol 2000, 74(3):232-236.
7. Hrushesky WJ, Bluming AZ, Gruber SA, Sothern RB: Menstrual influence on surgical cure of breast cancer. Lancet 1989, 2(8669):949-952.
8. Hrushesky WJ, Gruber SA, Sothern RB, Hoffman RA, Lakatua D, Carlson A, Cerra F, Simmons RL: Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Natl Cancer Inst 1988, 80(15):1232-1237.
9. Clarke RB, Howell A, Anderson E: Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 1997, 75(2):251-257.
10. Dabrosin C: Increase of free insulin-like growth factor-I in normal human breast in vivo late in the menstrual cycle. Breast Cancer Res Treat 2003, 80(2):193-198.
11. Lavigne JA, Wimbrow HH, Clevidence BA, Albert PS, Reichman ME, Campbell WS, Giffen LA, Dorgan JF, Hartman TJ, Barrett JC, Hursing SD, Taylor PR: Effects of alcohol and menstrual cycle on insulin-like growth factor-I and insulin-like growth factor binding protein-3. Cancer Epidemiol Biomarkers Prev 2004, 13(12):2264-2267.
12. Wood PA, Bove K, You S, Chambers A, Hrushesky WJ: Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther 2005, 4(7):1065-1075.
13. Coradini D, Veneroni S, Pellizzaro C, Daidone MG: Fluctuation of intratumor biological variables as a function of menstrual timing of surgery for breast cancer in premenopausal patients. Ann Oncol 2003, 14(6):962-964.
14. Navarrete MA, Maier CM, Falzoni R, Quadros LG, Lima GR, Baracat EC, Nazario AC: Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res 2005, 7(3):R306-R313.
15. Soderqvist G, Isaksson E, von SB, Carlstrom K, Tani E, Skoog L: Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997, 176(1 Pt 1):123-128.
16. Ramakrishnan R, Khan SA, Badve S: Morphological changes in breast tissue with menstrual cycle. Mod Pathol 2002, 15(12):1348-1356.
17. Ryan KJ: Biochemistry of aromatase: significance to female reproductive physiology. Cancer Res 1982, 42(8 Suppl):3342s-3344s.
18. Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995, 6(2):137-141.
19. Wood PA, Hrushesky WJ: Sex cycle modulates cancer growth. Breast Cancer Res Treat 2005, 91(1):95-102.
20. Shakhar K, Shakhar G, Rosenne E, Ben-Eliyahu S: Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br J Cancer 2000, 83(12):1630-1636.
21. Ben-Eliyahu S, Shakhar G, Shakhar K, Melamed R: Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications. Br J Cancer 2000, 83(12):1747-1754.
22. Dabrosin C: Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle. J Clin Endocrinol Metab 2003, 88(6):2695-2698.
23. McIlhenny C, George WD, Doughty JC: A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. Br J Cancer 2002, 86(11):1786-1789.
24. Heer K, Kumar H, Speirs V, Greenman J, Drew PJ, Fox JN, Carleton PJ, Monson JR, Kevin MJ: Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery? Br J Cancer 1998, 78(9):1203-1207.
25. Oliver DJ, Ingram DM: Timing of surgery during the menstrual cycle for breast cancer: possible role of growth factors. Eur J Cancer 1995, 31A(3):325-328.
26. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau, Hugol D, Audouin J, Leygue E, Truc JB, Poitout P: Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat 1996, 38(2):227-235.
27. Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD, Fentiman IS: Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991, 337(8752):1261-1264.
28. Badwe RA, Mittra I, Havaldar R: Timing of surgery during the menstrual cycle and prognosis of breast cancer. J Biosci 2000, 25(1):113-120.
29. Fentiman IS: 12. Timing of surgery for breast cancer. Int J Clin Pract 2002, 56(3):188-190.
30. Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T: A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma. Cancer 2001, 91(10):1854-1861.
31. Takeda Y, Yanagie H, Yoshizaki I, Eriguchi M: Does the timing of surgery for breast cancer in relation to the menstrual cycle or geomagnetic activity affect prognoses of premenopausal patients? Biomed Pharmacother 2003, 57(Suppl 1):96s-103s.
32. Nomura Y, Kataoka A, Tsutsui S, Murakami S, Takenaka Y: Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer. Eur J Cancer 1999, 35(9):1326-1330.
33. Mangia A, De LM, Barletta A, Marzullo F, Attolico M, Stea B, Petroni S, Labriola A, Cellamare G, Digiebi G, Altieri R, Schittuli F, Paradiso A: Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and shortterm clinical outcome. J Exp Clin Cancer Res 1998, 17(3):317-323.
34. Paradiso A, Serio G, Fanelli M, Mangia A, Cellamare G, Schittulli F: Predictability of monthly and yearly rhythms of breast cancer features. Breast Cancer Res Treat 2001, 67(1):41-49.
35. Goldhirsch A, Gelber RD, Castiglione M, O'Neill A, Thurlimann B, Rudenstam CM, Lindtner J, Collins J, Forbes J, Crivellani D, Coates A, Cavalli F, Simoncini E, Fey MF, Pagani O, Price K, Senn HJ: Menstrual cycle and timing of breast surgery in premenopausal nodepositive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann Oncol 1997, 8(8):751-756.
36. Vanek VW, Kadivar TF, Bourguet CC: Correlation of menstrual cycle at time of breast cancer surgery to disease-free and overall survival. South Med J 1997, 90(8):780-788.
37. Mondini G, Decian F, Sorice G, Friedman D, Spirito C, Costantini M, Sormani MP, Civalleri D: Timing of surgery related to menstrual cycle and prognosis of premenopausal women with breast cancer. Anticancer Res 1997, 17(1B):787-790.
38. Jager W, Sauerbrei W: Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients. Breast Cancer Res Treat 1995, 34(3):279-287.
39. Holli K, Isola J, Hakama M: Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient-fact or fallacy. Br J Cancer 1995, 71(1):124-127.
40. Kroman N, Hoigaard A, Andersen KW, Graversen HP, Afzelius P, Lokdam A, Juul C, Hoffmann J, Bentzon N, Mouridsen HT: Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group. Eur J Surg Oncol 1994, 20(4):430-435.
41. Corder AP, Cross M, Julious SA, Mullee MA, Taylor I: The timing of breast cancer surgery within the menstrual cycle. Postgrad Med J 1994, 70(822):281-284.
42. Saad Z, Vincent M, Bramwell V, Stitt L, Duff J, Girotti M, Jory T, Heathcote G, Turnbull I, Garcia B: Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer. Eur J Cancer 1994, 30A(9):1348-1352.
43. Gnant MF, Seifert M, Jakesz R, Adler A, Mittlboeck M, Sevelda P: Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women. Int J Cancer 1992, 52(4):707-712.
44. Senie RT, Rosen PP, Rhodes P, Lesser ML: Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med 1991, 115(5):337-342.